Aflac (NYSE:AFL – Get Free Report) released its earnings results on Wednesday. The financial services provider reported $1.83 earnings per share for the quarter, beating the consensus estimate of $1.60 by $0.23, Briefing.com reports. The company had revenue of $5.14 billion during the quarter, compared to the consensus estimate of $4.10 billion. Aflac had a return on equity of 16.88% and a net margin of 27.67%. Aflac’s revenue was down .7% compared to the same quarter last year. During the same period in the previous year, the company posted $1.58 EPS.
Aflac Stock Up 6.6 %
AFL stock traded up $6.27 during trading on Thursday, hitting $101.65. 7,183,356 shares of the company’s stock were exchanged, compared to its average volume of 2,220,250. The business has a 50-day moving average price of $90.25 and a two-hundred day moving average price of $85.47. The stock has a market capitalization of $57.76 billion, a price-to-earnings ratio of 11.19, a PEG ratio of 2.60 and a beta of 0.95. Aflac has a 52-week low of $72.78 and a 52-week high of $104.91. The company has a current ratio of 0.08, a quick ratio of 0.08 and a debt-to-equity ratio of 0.34.
Aflac Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Monday, September 2nd. Investors of record on Wednesday, August 21st will be paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 1.97%. Aflac’s payout ratio is 22.08%.
Insider Buying and Selling
Wall Street Analysts Forecast Growth
Several equities analysts have weighed in on AFL shares. Jefferies Financial Group dropped their target price on Aflac from $84.00 to $83.00 and set a “hold” rating for the company in a research report on Friday, June 28th. Morgan Stanley lifted their target price on Aflac from $80.00 to $84.00 and gave the company an “equal weight” rating in a research report on Monday, April 15th. Keefe, Bruyette & Woods lifted their target price on Aflac from $83.00 to $87.00 and gave the company a “market perform” rating in a research report on Wednesday, April 10th. Piper Sandler lifted their target price on Aflac from $95.00 to $100.00 and gave the company an “overweight” rating in a research report on Friday, June 28th. Finally, Wells Fargo & Company lifted their target price on Aflac from $81.00 to $82.00 and gave the company an “equal weight” rating in a research report on Friday, May 10th. Two research analysts have rated the stock with a sell rating, nine have given a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $86.69.
View Our Latest Stock Report on Aflac
About Aflac
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
See Also
- Five stocks we like better than Aflac
- 3 Warren Buffett Stocks to Buy Now
- First Solar Stock: The Dawn of a New Rally in Share Prices
- The 3 Best Retail Stocks to Shop for in August
- Mastercard Stock’s Q2 Financial Results Outshine Competitors
- Short Selling: How to Short a Stock
- Tobacco Giant’s Shares Fall on EPS Miss, Lackluster Pouch Gains
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.